Labor Induction Outcomes with Outpatient Misoprostol for Cervical Ripening among Low-Risk Women
American Journal of Perinatology · 01.05.2024 · 41 (S 01 S 01) · e818-e826
DOI: 10.1055/a-1948-2779 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Perinatology, erschienen am 01.05.2024. Verfasst von Nazineen Kandahari und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of California San Francisco, San Francisco, California. Hauptthemen laut MEDLINE: Misoprostol, Labor, Induced, Cervical Ripening, Oxytocics. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: KPNC Graduate Medical Education, Kaiser Foundation Hospitals.
Abstract (Originalsprache)
Objective
In 2012, two Kaiser Permanente Northern California (KPNC) hospitals began offering outpatient cervical ripening with oral misoprostol under a study protocol. We evaluated inpatient time from admission to delivery and adverse maternal and neonatal outcomes associated with outpatient use of misoprostol for cervical ripening among low-risk women with term pregnancies. Study Design We conducted a retrospective cohort study comparing three groups: women who received misoprostol (1) outpatient, under a study protocol; (2) inpatient, at the study sites; and (3) inpatient, at all KPNC hospitals. Data were obtained from between 2012 and 2017. The primary outcome was time from inpatient admission to delivery. Secondarily, we evaluated maternal and neonatal outcomes, including the duration and maximum rate of oxytocin administered, rate of cesarean delivery, incidence of chorioamnionitis and blood transfusion, Apgar scores, and neonatal intensive care unit admissions. Demographic and clinical characteristics and outcomes of the outpatient group were compared with both inpatient misoprostol groups using the appropriate statistical test. Variables included in the regression analysis were either statistically significant in the bivariate analyses or have been reported in the literature to be potential confounders: maternal age at admission, race/ethnicity, body mass index, cervical dilation at initial misoprostol, and parity.
Results
We analyzed data from 10,253 patients: (1) 345 outpatients, under a study protocol; (2) 1,374 inpatients, at the study sites; and (3) 9,908 inpatients, at all the Kaiser hospitals. Women in the outpatient group were more likely to be white than both inpatient groups (63.3 vs. 56.3% at study sites and 47.1% in all hospitals, p = 0.002 and
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Medicine, University of California San Francisco, San Francisco, California.
- Division of Research, Kaiser Permanente, Oakland, California.
- Department of Obstetrics and Gynecology, Kaiser Permanente Northern California, Walnut Creek, California.
- Department of Obstetrics and Gynecology, George Washington University Medical Faculty Associates, Washington, District of Columbia.
Förderung
- KPNC Graduate Medical Education, Kaiser Foundation Hospitals
Zitieren
APA
Kandahari, N., Schneider, A. N., Tucker, L. S., Raine-Bennett, T. R., & Mohta, V. J. (2024). Labor Induction Outcomes with Outpatient Misoprostol for Cervical Ripening among Low-Risk Women. American Journal of Perinatology, 41(S 01 S 01), e818-e826. https://doi.org/10.1055/a-1948-2779
Vancouver
Kandahari N, Schneider AN, Tucker LS, Raine-Bennett TR, Mohta VJ. Labor Induction Outcomes with Outpatient Misoprostol for Cervical Ripening among Low-Risk Women. American Journal of Perinatology. 2024;41(S 01 S 01):e818-e826. doi:10.1055/a-1948-2779
BibTeX
@article{Kandahari2024,
author = {Kandahari, Nazineen and Schneider, Allison N and Tucker, Lue-Yen S and Raine-Bennett, Tina R and Mohta, Vanitha J},
title = {Labor Induction Outcomes with Outpatient Misoprostol for Cervical Ripening among Low-Risk Women},
journal = {American Journal of Perinatology},
year = {2024},
volume = {41},
number = {S 01 S 01},
pages = {e818--e826},
doi = {10.1055/a-1948-2779}
}
EUVIMED